http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Entourage Health Continues to Expand Medical Offerings with Launch of CBD Chewing Gum and Signs New Union Group to the Starseed Medicinal Program
-
Entourage Health Launches New Color Cannabis and Saturday Cannabis Products
-
Entourage Health and LiUNA Pension Fund Close on $15M of Previously Announced Debt Financing
-
Entourage Health's Color Cannabis Receives 2022 ADCANN Award for Canadian Marketing Campaign of the Year
-
Entegris (ENTG) Chief Financial Officer Greg Graves Plans to Retire
-
Entegris Chief Financial Officer Greg Graves Plans to Retire
-
Entegris Declares Quarterly Cash Dividend
-
Entourage Health Updates Senior Secured Amended and Restated Credit Facility
-
Entegris Announces Plans to Build New Manufacturing Center of Excellence in Colorado Springs
-
Entourage Health Reports Third Quarter 2022 Financial Results and Posts $13.4 Million in Total Revenue
-
Entourage Health to Host Third Quarter 2022 Financial Results Call on November 15
-
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $30 Million in Non-Dilutive Funding Availability
-
Entourage Launches New Suite of 15 Innovative Color Cannabis and Saturday Cannabis Products for its Largest Retail Product Call to Date
-
Entourage Launches Unique Medical Cannabis Marketplace “Syndicate” Offering Premium Craft Products From Collective of In-House and Third-Party Micro Producers
-
Entourage Health Appoints Seasoned Executive James Afara to Chief Operating Officer
-
Entourage Health Signs Four New Union Groups to its Starseed Medicinal Program
-
Entourage Health Reports Second Quarter 2022 Financial Results
-
Entourage Health Announces Second Quarter 2022 Financial Results Call to be held on August 30, 2022
-
Entourage Health Signs Exclusive Licensing Agreement with Irwin Naturals to Produce and Distribute its Cannabis Products in Canada
-
Entegris Reports Results for Second Quarter Of 2022
-
Entourage Health Provides Update on Credit Facilities’ Maturity Dates and Amends Outstanding Unsecured Convertible Debentures
-
Entourage Expands Medical Offerings with Launch of New Services and Products
-
Entegris Declares Quarterly Cash Dividend
-
Lam Research, Entegris, Gelest Team Up to Advance EUV Dry Resist Technology Ecosystem
-
Entegris to Report Results for Second Quarter of 2022 on Tuesday, August 2, 2022
-
Entegris Completes Acquisition of CMC Materials, Solidifying Position as the Global Leader in Electronic Materials
-
Entourage Health Announces Amendments to its Credit Facilities to Improve Debt Position and Support Strategic Long-Term Growth
-
Entourage Health Announces $8.9 Million Upsize to Credit Facility and Implementation of Proposed Amendments to 8.5% Unsecured Convertible Debentures
-
Entourage Health Provides Update on Proposed Amendments to its 8.5% Unsecured Convertible Debentures
-
Entourage Health Announces Debentureholders Overwhelmingly Approve Proposed Amendments to 8.5% Unsecured Convertible Debentures
-
Entourage Announces Results of 2022 Annual General Meeting of Shareholders
-
Entourage Health Extends its Senior Secured Credit Facility Maturity Date
-
Entourage Health Reports Record First Quarter 2022 Financial Results
-
Entourage Health Announces Canadian Debut of The Boston Beer Company’s New Cannabis-Infused Iced Tea Beverages ‘TeaPot’
-
The Boston Beer Company Introduces TeaPot, A New Line of Cannabis-Infused Iced Teas
-
Entourage Health Reaffirms First Quarter 2022 Preliminary Record Revenues of $17.4 Million and Announces Financial Results Call to be held on May 31, 2022
-
Entourage Health Enters into Voting Support Agreement and Announces Proposed Amendments to its 8.5% Unsecured Convertible Debentures
-
Entourage Health to Present at the Canaccord Genuity 6th Annual Global Cannabis Virtual Conference on May 11th
-
Entourage Reports Record Fiscal Year 2021 Financial Results with $55.2 Million in Total Revenue for a 56% Year-Over-Year Increase and Preliminary Q1 2022 Record Revenue of $17.4 Million
-
Entourage Health Announces Issuance of Cease Trade Order
-
Entourage Health Partners with Pineapple Express to Provide Same-Day Medical Cannabis Delivery Service to its Starseed Medicinal Patients
-
Entourage Health Reschedules Full-Year 2021 Earnings Release and Conference Call to Align with First Quarter 2022 Results
-
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $15 Million in Funding Availability
-
Entourage Updates Timing of Fiscal Year 2021 Financial Results Call to May 3, 2022
-
Entourage Health Extends Senior Secured Credit Facility Maturity Date
-
Entourage Health Launches ‘Joints for Justice’ Retail Campaign to Raise Funds and Awareness in Support of Cannabis Amnesty
-
Entourage Health Appoints Finance Executive Vaani Maharaj as New Chief Financial Officer and Updates Timing of Q4 and Full-Year 2021 Financials to April 26
-
Entourage Health Debuts New 2022 Color Cannabis Branding Campaign and Celebrates All-Female-Led Marketing and Promotions Team
-
Entourage Health Announces Preliminary Fiscal Year 2021 Record Revenue of $54.8 Million with Q4 and Full-Year 2021 Financials to be filed by April 1, 2022
-
Entourage Health Posts New Year 2022 Shareholder Newsletter

